DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,129 filers reported holding DANAHER CORPORATION in Q1 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248,100 | +3.4% | 1,000 | 0.0% | 0.04% | +10.8% |
| Q2 2023 | $240,000 | +86542.6% | 1,000 | -9.1% | 0.04% | -14.0% |
| Q1 2023 | $277 | -5.1% | 1,100 | 0.0% | 0.04% | -8.5% |
| Q4 2022 | $292 | -99.9% | 1,100 | 0.0% | 0.05% | -6.0% |
| Q3 2022 | $284,000 | +1.8% | 1,100 | 0.0% | 0.05% | +11.1% |
| Q2 2022 | $279,000 | -14.4% | 1,100 | -1.0% | 0.04% | 0.0% |
| Q1 2022 | $326,000 | -9.9% | 1,111 | +1.0% | 0.04% | -10.0% |
| Q4 2021 | $362,000 | +8.1% | 1,100 | 0.0% | 0.05% | +8.7% |
| Q3 2021 | $335,000 | +13.6% | 1,100 | 0.0% | 0.05% | +21.1% |
| Q2 2021 | $295,000 | +19.0% | 1,100 | 0.0% | 0.04% | +15.2% |
| Q1 2021 | $248,000 | -7.1% | 1,100 | -8.3% | 0.03% | -19.5% |
| Q4 2020 | $267,000 | +3.5% | 1,200 | 0.0% | 0.04% | -22.6% |
| Q3 2020 | $258,000 | +16.7% | 1,200 | -4.0% | 0.05% | -1.9% |
| Q2 2020 | $221,000 | -78.4% | 1,250 | -81.3% | 0.05% | -69.3% |
| Q4 2019 | $1,024,000 | -0.1% | 6,675 | -6.0% | 0.18% | -5.4% |
| Q3 2019 | $1,025,000 | -6.3% | 7,100 | -7.3% | 0.19% | -3.1% |
| Q2 2019 | $1,094,000 | +42.8% | 7,655 | +32.0% | 0.19% | +38.1% |
| Q1 2019 | $766,000 | +42.9% | 5,800 | +11.5% | 0.14% | +28.7% |
| Q4 2018 | $536,000 | -5.3% | 5,200 | -0.2% | 0.11% | +4.9% |
| Q3 2018 | $566,000 | +10.1% | 5,213 | 0.0% | 0.10% | +6.2% |
| Q2 2018 | $514,000 | +0.8% | 5,213 | 0.0% | 0.10% | -2.0% |
| Q1 2018 | $510,000 | +5.4% | 5,213 | 0.0% | 0.10% | +2.1% |
| Q4 2017 | $484,000 | +8.3% | 5,213 | 0.0% | 0.10% | +11.5% |
| Q3 2017 | $447,000 | +3.5% | 5,213 | +1.7% | 0.09% | +1.2% |
| Q2 2017 | $432,000 | +0.9% | 5,125 | +2.5% | 0.09% | -2.3% |
| Q1 2017 | $428,000 | +10.0% | 5,000 | 0.0% | 0.09% | +8.6% |
| Q4 2016 | $389,000 | +54.4% | 5,000 | +100.0% | 0.08% | +55.8% |
| Q2 2016 | $252,000 | – | 2,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |